Mankind Pharma Ltd Sees Surge with 6,628 Active Call Options at Rs 2,500 Strike
Mankind Pharma Ltd has become one of the most actively traded stocks, particularly in call options expiring on July 31, 2025. The stock has shown strong performance, outpacing its sector, and remains above several key moving averages, despite a decline in delivery volume. The company's market cap stands at Rs 1,03,863.19 crore.
Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today. The company’s underlying stock, MANKIND, has seen significant trading activity, particularly in call options set to expire on July 31, 2025. Notably, 6,628 contracts were traded at a strike price of Rs 2,500, contributing to a turnover of approximately Rs 1,236.75 lakhs. The open interest stands at 980 contracts, indicating ongoing interest in this option.In terms of performance, Mankind Pharma has outperformed its sector by 2.64%, with a consecutive gain over the last two days, yielding a total return of 3.72%. The stock reached an intraday high of Rs 2,532, reflecting a 2.81% increase. The weighted average price suggests that more volume was traded closer to the lower price levels, while the stock remains above its 5-day, 20-day, 50-day, and 100-day moving averages, although it is below the 200-day moving average.
Despite a notable decline in delivery volume, which fell by 72.57% compared to the 5-day average, Mankind Pharma maintains sufficient liquidity for trades, with a market cap of Rs 1,03,863.19 crore. Overall, the stock's recent activity highlights its dynamic position within the market, underscoring the ongoing interest from traders.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
